JIHYUN YOON: Open Payments
NPI 1891458220 · MC LEAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 56 payments from 15 companies in 2025. Trend: 2023 $755 · 2024 $1,084 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 13 | $269 |
| Regeneron Healthcare Solutions, Inc. | 8 | $168 |
| Ardelyx, Inc. | 9 | $155 |
| Madrigal Pharmaceuticals | 1 | $149 |
| Phathom Pharmaceuticals, Inc. | 6 | $89 |
| PFIZER INC. | 4 | $87 |
| Janssen Biotech, Inc. | 3 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Novo Nordisk Inc | 2 | $50 |
| Braintree Laboratories, Inc. | 2 | $48 |
Products named: Sucraid, IBSRELA, REZDIFFRA, VOQUEZNA, TREMFYA, DUPIXENT, XIFAXAN, Wegovy.
Industry payments across VA — which companies pay providers there.
